Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1980 Jul 5;281(6232):24-5.
doi: 10.1136/bmj.281.6232.24.

D-propranolol and DL-propranolol both decrease conversion of L-thyroxine to L-triiodothyronine

Clinical Trial

D-propranolol and DL-propranolol both decrease conversion of L-thyroxine to L-triiodothyronine

P Heyma et al. Br Med J. .

Abstract

The effects of propranolol (DL-propranolol) and D-propranolol on thyroid hormone metabolism were studied in six euthyroid volunteers receiving L-thyroxine (T4) and six hypothyroid patients receiving T4 replacement. D-propranolol as well as propranolol decreased L-triiodothyronine (T3) concentrations and the ratio of T3 to T4 in the euthyroid subjects, and D-propranolol decreased these variables in the subjects with hypothyroidism (propranolol was not given to this group). It is concluded from this study and from parallel invitro investigations that the effect of propranolol on the conversion of T4 to T3 is unrelated to its beta-adrenergic blocking activity, and that at low therapeutic doses propranolol may exert appreciable "membrane-stabilising" effects in vivo.

PubMed Disclaimer

References

    1. Lancet. 1969 May 17;1(7603):993-4 - PubMed
    1. Br J Clin Pharmacol. 1976 Apr;3(2):273-7 - PubMed
    1. J Clin Endocrinol Metab. 1977 May;44(5):1002-5 - PubMed
    1. Clin Endocrinol (Oxf). 1977 Jun;6(6):405-10 - PubMed
    1. Clin Endocrinol (Oxf). 1977 Jul;7(1):41-4 - PubMed

Publication types

LinkOut - more resources